Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · Real-Time Price · USD

6.19

+0.03 (0.49%)

At close: Jan 21, 2025, 4:00 PM

6.25

+0.06 (0.97%)

After-hours: Jan 21, 2025, 4:30 PM EST

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics has a market cap or net worth of $277.24 million as of January 21, 2025. Its market cap has decreased by -3.26% in one year.

Market Cap

277.24M

Enterprise Value

213.33M

1-Year Change

-3.26%

Ranking

#3433

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $277.24M, a decrease of -65.20%. That is a compound annual growth rate of -15.36%.

Market Cap History

Date	Market Cap	% Change
Jan 17, 2025	275.90M	-21.33%
Dec 31, 2024	350.70M	17.88%
Dec 29, 2023	297.50M	39.61%
Dec 30, 2022	213.10M	-69.88%
Dec 31, 2021	707.47M	-64.73%
Dec 31, 2020	2.01B	61.56%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	653.46B
UnitedHealth Group	469.12B
Johnson & Johnson	353.99B
Novo Nordisk	352.70B
AbbVie	303.17B
Merck & Co.	247.70B
Thermo Fisher Scientific	214.07B
Intuitive Surgical	211.09B

Market Cap Rankings